-
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
Friday, May 17, 2024 - 1:13pm | 433Read More...Investors demanded more clarity from German healthcare group Fresenius SE regarding its intentions to relinquish strategic control over dialysis group Fresenius Medical Care AG (NYSE:FMS). The investors’ call for transparency comes in the wake of Fresenius’s...
-
Highlights From The Deutsche Bank ADR Virtual Investor Conference
Monday, December 9, 2019 - 7:16am | 1624Read More...The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Nine international companies recently made their pitch to investors at the Deutsche Bank Depositary Receipts Virtual Investor Conference,...
-
Fresenius Investigates Akorn FDA Compliance, Says Outcome May Affect Merger
Tuesday, February 27, 2018 - 9:12am | 282Read More...What Happened Akorn, Inc. (NASDAQ: AKRX) shares fell more than 30 percent Monday evening after Fresenius Kabi AG announced an independent investigation into alleged breaches of FDA data integrity requirements related to product development. Akorn later released a statement confirming its active...
-
9 Times Executives Were Poached
Saturday, September 3, 2016 - 10:49am | 537Read More...United Continental Holdings Inc (NYSE: UAL) has stepped in and snatched up former American Airlines Group Inc (NASDAQ: AAL) president Scott Kirby. Luring talent from the workforce of competitors is known as “poaching,” and it’s certainly nothing new on Wall Street, especially...
-
Fresenius SE, Permira Interested In Acquiring Danone's Medical Unit
Wednesday, November 19, 2014 - 4:13pm | 225Read More...German based health care group Fresenius SE and European buyout firm Permira have made a joint bid to acquire Danone's (OTC: DANOY) medical nutrition business for as much as 4.5 billion euro. The Wall Street Journal reported Wednesday afternoon that Danone will entertain other offers...
